Histogen Profit Margin

Histogen (HSTO) currently reports a profit margin of -65173.68% as of September 2023. That compares with -299.2% in the prior-year period — down 21682.3% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Histogen's profit margin history and peer comparisons.

Histogen's profit margin decreased from -299.2% to -65173.68% — a 21682.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Histogen's profit margin of -65173.68% is lower than the Healthcare sector average of 19.13%. That is roughly 340765.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Histogen's current -65173.68% should be judged against Healthcare norms (sector average: 19.13%) and against HSTO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -65173.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Histogen, and consider following HSTO for alerts when major investors trade the stock.